Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
Clinical trial NCT01445379 · COMPLETED
Trial details
- NCT number
- NCT01445379
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2014-04-18
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.